Skip to main content

Advertisement

Log in

Proposal for a tumor budding predictive score derived from endoscopic biopsy samples in colorectal cancer

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

In colorectal cancer, tumor budding is highlighted as both a prognostic indicator and a predictor of chemosensitivity. However, tumor budding has a serious drawback because of unattainable preoperative assessment, thereby, making it not applicable to decision-making on treatment strategies. Recently, high expressions of seven genes (i.e., MSLN, SLC4A11, WNT11, SCEL, RUNX2, MGAT3, and FOXC1) were shown to be associated with high-budding colorectal cancers. This study aimed to propose a budding prediction system using selected RNAs extracted from biopsy specimens.

Methods

The RNA expression levels in 86 surgically resected samples and in 104 samples obtained by colonoscopy before surgery were investigated.

Results

The tumor surface expressions of four exclusive genes (i.e., MSLN, SLC4A11, SCEL, and MGAT3) were correlated with the tumor budding grade. Subsequently, the logit P value calculated by multiple logistic regression analysis using the four surface gene expressions was set as the following budding predictive score: Logit (P) =  − 0.55 + 0.27*MSLN + 0.16*SLC4A11 + 0.06*MGAT3 + 0.21*SCEL. The effectiveness of the model using colorectal cancer biopsy samples was well corroborated prospectively.

Conclusion

The budding predictive score that we developed using endoscopic biopsy specimens was clarified to have a high potential for preoperative use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Lugli A, Kirsch R, Ajioka Y et al (2017) Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol 30:1299–1311

    Article  Google Scholar 

  2. Rogers AC, Winter DC, Heeney A et al (2016) Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer. Br J Cancer 115:831–840

    Article  CAS  Google Scholar 

  3. Sy J, Fung CL, Dent OF et al (2010) Tumor budding and survival after potentially curative resection of node-positive colon cancer. Dis Colon Rectum 53:301–307

    Article  Google Scholar 

  4. Shinto E, Jass JR, Tsuda H et al (2006) Differential prognostic significance of morphologic invasive markers in colorectal cancer: tumor budding and cytoplasmic podia. Dis Colon Rectum 49:1422–1430

    Article  Google Scholar 

  5. Ueno H, Murphy J, Jass JR et al (2002) Tumour ‘budding’ as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40:127–132

    Article  CAS  Google Scholar 

  6. Ueno H, Ishiguro M, Nakatani E et al (2019) Prospective multicenter study on the prognostic and predictive impact of tumor budding in stage II colon cancer: results from the SACURA trial. J Clin Oncol 37:1886–1894

    Article  CAS  Google Scholar 

  7. Yamadera M, Shinto E, Kajiwara Y et al (2019) Differential survival benefits of 5-fluorouracil-based adjuvant chemotherapy for patients with microsatellite-stable Stable III colorectal cancer according to the tumor budding status: a retrospective analysis. Dis Colon Rectum 62:1316–1325

    Article  Google Scholar 

  8. Nagata K, Shinto E, Yamadera M et al (2020) Prognostic and predictive values of tumor budding in stage IV colorectal cancer. BJS Open 4:693–703

    Article  CAS  Google Scholar 

  9. Zlobec I, Hädrich M, Dawson H et al (2014) Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients. Br J Cancer 110:1008–1013

    Article  CAS  Google Scholar 

  10. Giger OT, Comtesse SC, Lugli A et al (2012) Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer. Mod Pathol 25:1048–1053

    Article  Google Scholar 

  11. Lugli A, Vlajnic T, Giger O et al (2011) Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients. Hum Pathol 42:1833–1840

    Article  Google Scholar 

  12. Rogers AC, Gibbons D, Hanly AM et al (2014) Prognostic significance of tumor budding in rectal cancer biopsies before neoadjuvant therapy. Mod Pathol 27:156–162

    Article  Google Scholar 

  13. Shinto E, Yoshida Y, Kajiwara Y et al (2020) Clinical significance of a gene signature generated from tumor budding grade in colon cancer. Ann Surg Oncol 27:4044–4054

    Article  Google Scholar 

  14. Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM classification of malignant tumors, 7th edn. Wiley-Blackwell, Hoboken

    Google Scholar 

  15. Shiraishi T, Shinto E, Mochizuki S et al (2019) Mesothelin expression has prognostic value in stage II/III colorectal cancer. Virchows Arch 474:297–307

    Article  CAS  Google Scholar 

  16. Fukazawa S, Shinto E, Tsuda H et al (2015) Laminin β3 expression as a prognostic factor and a predictive marker of chemoresistance in colorectal cancer. Jpn J Clin Oncol 45:533–540

    PubMed  Google Scholar 

  17. Youden WJ (1950) Index for rating diagnostic tests. Cancer 3:32–35

    Article  CAS  Google Scholar 

  18. Prieve MG, Moon RT (2003) Stromelysin-1 and mesothelin are differentially regulated by Wnt-5a and Wnt-1 in C57 mg mouse mammary epithelial cells. BMC Dev Biol 3:2

    Article  Google Scholar 

  19. Uysal-Onganer P, Kypta RM (2012) Wnt11 in 2011—the regulation and function of a non-canonical Wnt. Acta Physiol (Oxf) 204:52–64

    Article  CAS  Google Scholar 

  20. Chou CK, Fan CC, Lin PS et al (2016) Sciellin mediates mesenchymal-to-epithelial transition in colorectal cancer hepatic metastasis. Oncotarget 7:25742–25754

    Article  Google Scholar 

  21. Gaur T, Lengner CJ, Hovhannisyan H et al (2005) Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280:33132–33140

    Article  CAS  Google Scholar 

  22. Shinto E, Tsuda H, Ueno H et al (2005) Prognostic implication of laminin-5 gamma 2 chain expression in the invasive front of colorectal cancers, disclosed by area-specific four-point tissue microarrays. Lab Invest 85:257–266

    Article  CAS  Google Scholar 

  23. Kajiwara Y, Ueno H, Hashiguchi Y et al (2011) Expression of l1 cell adhesion molecule and morphologic features at the invasive front of colorectal cancer. Am J Clin Pathol 136:138–144

    Article  CAS  Google Scholar 

  24. Kajiwara Y, Ueno H, Hashiguchi Y et al (2011) Heterogeneity of metalloproteinase expression in colorectal cancer—relation of molecular findings to basic morphology. Anticancer Res 31:1567–1575

    CAS  PubMed  Google Scholar 

  25. Shiraishi T, Shinto E, Nearchou IP et al (2020) Prognostic significant of mesothelin expression in colorectal cancer disclosed by area-specific four-point tissue microarrays. Virchows Arch 477:409–420

    Article  CAS  Google Scholar 

  26. Shiraishi T, Shinto E, Yamadera M et al (2020) Significance of mesothelin expression in preoperative endoscopic biopsy specimens for colorectal cancer prognosis. Oncotarget 11:3807–3817

    Article  Google Scholar 

  27. Kohler RS, Anugraham M, Lopez MN et al (2016) Epigenetic activation of MGAT3 and corresponding bisecting GlcNAc shortens the survival of cancer patients. Oncotarget 7:51674–51686

    Article  Google Scholar 

  28. De Cristofaro R, De Filippis V (2003) Interaction of the 268–282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII. Biochem J 373:593–601

    Article  Google Scholar 

  29. Ehrlich M (2009) DNA hypomethylation in cancer cells. Epigenomics 1:239–259

    Article  CAS  Google Scholar 

  30. Qin L, Li T, Liu Y (2017) High SLC4A11 expression is an independent predictor for poor overall survival in grade 3/4 serous ovarian cancer. PLoS ONE 12:e0187385

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported in part by the Japan Society for the Promotion of Science KAKENHI (18K08721). The authors thank Y. Hasumi for the expert technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eiji Shinto.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamadera, M., Shinto, E., Nagata, K. et al. Proposal for a tumor budding predictive score derived from endoscopic biopsy samples in colorectal cancer. Int J Clin Oncol 27, 756–764 (2022). https://doi.org/10.1007/s10147-021-02104-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-021-02104-6

Keywords

Navigation